THROMBOPROPHYLAXIS IMPACT IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC SURGERY IN SUDAN

  • Abubaker Aldosh Faculty of graduate studies, Omdurman Islamic University, Khartoum, Sudan.
  • Kholoud Hamad Faculty of graduate studies, Omdurman Islamic University, Khartoum, Sudan.
  • Ali Hashim Faculty of graduate studies, Omdurman Islamic University, Khartoum, Sudan.
  • Aziza Mohammed Faculty of graduate studies, Omdurman Islamic University, Khartoum, Sudan.
  • Osman Babiker Faculty of graduate studies, Omdurman Islamic University, Khartoum, Sudan.
  • Ali Awadallah Saeed Department of pharmacology and therapeutics, Pharmacy program, Napata College, Khartoum, Sudan.
  • Mohamed A. Mousnad Department of pharmacy practice, faculty of pharmacy, international university of Africa, Sudan.
10.22270/ujpr.v5i3.415

Keywords:

Deep-vein thrombosis, incidence, orthopedic surgery, venous thromboembolism

Abstract

Objective: Venous thromboembolism is an important complication of major orthopedic surgery. The aim of present study was to investigate the efficacy of the currently used thromboprophylaxis protocol, determine the incidence of VTE post operatively and the risk factors behind it in patients undergoing major orthopedic surgery.

Methods: A retrospective descriptive study for 403 patients underwent major orthopedic surgery from July 2013 to July 2014 in main hospitals in Khartoum state where major orthopedic surgery performed. Data were collected using observation checklist and analyzed using SPSS version 22 to study the association between the type of surgery, patient’s risk factors, choice and duration of thromboprophylaxis and development of VTE after major orthopedic surgery.

Results: Total 403 patients were incorporated the study, 2.73% were diagnosed with DVT developed within 5 days post operatively. 1.64% of the patients not received any type of thromboprophylaxis, 0.27% wore compression stocking. Pharmacological methods were used in the rest of the patients, 96.72% administered to them enoxaparine. 75.95% of the patients presented with one or more than one risk factors for VTE other than the orthopedic surgery. 4% of patients received thromboprophylaxis for more than 14 days while 96% received it for 3-5 days. The incidence of DVT was higher in diabetic patients (p- value= 0.03) and hypertensive (p- value= 0.046) who aged ≥60 years.

Conclusion: Results showed that VTE was a significant complication of major orthopedic surgery, despite the use of thromboprophylaxis and the incidence was 2.73% in our study.

                           r92.gif

Peer Review History:

Received 8 April 2020; Revised 7 May; Accepted 24 June; Available online 15 July 2020

Academic Editor: Essam Mohamed Eissaorcid22.jpg, Beni-Suef University, Egypt, dressamceutics@yahoo.com

Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 5.5/10

Average Peer review marks at publication stage: 7.0/10

Reviewer(s) detail:

Dr. Michael Otakhor Erhunmwunseorcid2.jpg, St. Philomena Catholic Hospital, Nigeria, dedoctor4life@gmail.com

Francesco Ferrara, USL Umbriaorcid2.jpg, Pharmacy Department, Perugia, Italy, francesco.ferrara@uslumbria1.it

Downloads

Download data is not yet available.
Crossmark
Statistics
312 Views | 213 Downloads
Dimension Citations

Published

2020-07-15

How to Cite

Aldosh, A., K. Hamad, A. Hashim, A. Mohammed, O. Babiker, A. A. Saeed, and M. A. Mousnad. “THROMBOPROPHYLAXIS IMPACT IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC SURGERY IN SUDAN”. Universal Journal of Pharmaceutical Research, vol. 5, no. 3, July 2020, doi:10.22270/ujpr.v5i3.415.

Issue

Section

Research Articles
Share |

Most read articles by the same author(s)